Pubblicazioni

CDK4/6 Inhibitors in Combination Therapies: Better in Company Than Alone: A Mini Review

2022 - FRONTIERS IN ONCOLOGY
Rampioni Vinciguerra, Gian Luca; Sonego, Maura; Segatto, Ilenia; Dall’Acqua, Alessandra; Vecchione, Andrea; Baldassarre, Gustavo; Belletti, Barbara

Chemotherapeutic risk incRNA-PVT1 SNP sensitizes metastatic colorectal cancer to FOLFOX regimen

2022 - FRONTIERS IN ONCOLOGY
Wu, S.; Yang, X.; Tang, W.; Familiari, G.; Relucenti, M.; Aschner, M.; Li, X.; Chen, R.

Editorial: Women in colorectal cancers

2022 - FRONTIERS IN ONCOLOGY
De Felice, Francesca

Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review

2022 - FRONTIERS IN ONCOLOGY
Rizzo, S.; Raia, G.; Del Grande, M.; Gasparri, M. L.; Colombo, I.; Manganaro, L.; Papadia, A.; Del Grande, F.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma